[Role and use of biphosphonates in the treatment of metastatic breast cancer].
Caulin
F
F
RORER International, Fort Washington, PA 19034.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000097:blood / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology*; D004002:Clodronic Acid / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D063065:Organophosphonates / Q000627:therapeutic use*; D010014:Osteolysis / Q000150:complications / Q000188:drug therapy*
D000970:Antineoplastic Agents; D063065:Organophosphonates; D004002:Clodronic Acid
Rôle et utilisation des bisphosphonates dans le traitement des cancers du sein métastatiques.